Literature DB >> 23868749

Impact of osmotically active excipients on bioavailability and bioequivalence of BCS class III drugs.

Mei-Ling Chen1, Nakissa Sadrieh, Lawrence Yu.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23868749      PMCID： PMC3787221          DOI： 10.1208/s12248-013-9509-z

Source DB:  PubMed          Journal:  AAPS J        ISSN： 1550-7416            Impact factor:   4.009


× No keyword cloud information.
  37 in total

Review 1.  The biopharmaceutics classification system (BCS): class III drugs - better candidates for BA/BE waiver?

Authors:  H H Blume; B S Schug
Journal:  Eur J Pharm Sci       Date:  1999-12       Impact factor: 4.384

Review 2.  Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system.

Authors:  Chi-Yuan Wu; Leslie Z Benet
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

Review 3.  Osmosis and solute-solvent drag: fluid transport and fluid exchange in animals and plants.

Authors:  H T Hammel; Whitney M Schlegel
Journal:  Cell Biochem Biophys       Date:  2005       Impact factor: 2.194

4.  In vitro - in vivo correlation: from theory to applications.

Authors:  Jaber Emami
Journal:  J Pharm Pharm Sci       Date:  2006       Impact factor: 2.327

5.  The effect of mannitol on the oral bioavailability of cimetidine.

Authors:  D A Adkin; S S Davis; R A Sparrow; P D Huckle; I R Wilding
Journal:  J Pharm Sci       Date:  1995-12       Impact factor: 3.534

6.  Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies.

Authors:  Qi Shen; Yulian Lin; Takahiro Handa; Masamichi Doi; Masami Sugie; Kana Wakayama; Naoki Okada; Takuya Fujita; Akira Yamamoto
Journal:  Int J Pharm       Date:  2006-02-24       Impact factor: 5.875

7.  Interaction of polysorbate 80 with erythropoietin: a case study in protein-surfactant interactions.

Authors:  Annabelle P Villalobos; Srinivas R Gunturi; George A Heavner
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

8.  Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteers.

Authors:  I Ragueneau; J M Poirier; N Radembino; A B Sao; C Funck-Brentano; P Jaillon
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

9.  Reaction to the paper: interaction of polysorbate 80 with erythropoietin: a case study in protein-surfactant interactions.

Authors:  Suzanne Hermeling; Wim Jiskoot; Daan J A Crommelin; Huub Schellekens
Journal:  Pharm Res       Date:  2006-03-15       Impact factor: 4.200

10.  A modern view of excipient effects on bioequivalence: case study of sorbitol.

Authors:  M-L Chen; A B Straughn; N Sadrieh; M Meyer; P J Faustino; A B Ciavarella; B Meibohm; C R Yates; A S Hussain
Journal:  Pharm Res       Date:  2006-10-18       Impact factor: 4.580
View more
  6 in total

1.  Using Physiologically Based Pharmacokinetic (PBPK) Modeling to Evaluate the Impact of Pharmaceutical Excipients on Oral Drug Absorption: Sensitivity Analyses.

Authors:  Edwin Chiu Yuen Chow; Arjang Talattof; Eleftheria Tsakalozou; Jianghong Fan; Liang Zhao; Xinyuan Zhang
Journal:  AAPS J       Date:  2016-08-12       Impact factor: 4.009

2.  In Vitro and In Vivo Inhibition of Intestinal Glucose Transport by Guava (Psidium Guajava) Extracts.

Authors:  Ulrike Müller; Flora Stübl; Bettina Schwarzinger; Georg Sandner; Marcus Iken; Markus Himmelsbach; Clemens Schwarzinger; Nicole Ollinger; Verena Stadlbauer; Otmar Höglinger; Tobias Kühne; Peter Lanzerstorfer; Julian Weghuber
Journal:  Mol Nutr Food Res       Date:  2018-05-17       Impact factor: 5.914

Review 3.  Accelerating Drug Development in Pediatric Oncology With the Clinical Pharmacology Storehouse.

Authors:  Mohamad Shebley; Rajeev M Menon; John P Gibbs; Nimita Dave; Su Y Kim; Patrick J Marroum
Journal:  J Clin Pharmacol       Date:  2018-12-18       Impact factor: 3.126

Review 4.  Evaluation of Excipient Risk in BCS Class I and III Biowaivers.

Authors:  Melissa Metry; James E Polli
Journal:  AAPS J       Date:  2022-01-05       Impact factor: 4.009

5.  Digoxin absorption decreased independently of P-gp activity in rats with irinotecan-induced gastrointestinal damage.

Authors:  Toshiaki Tsuchitani; Takeshi Akiyoshi; Ayuko Imaoka; Hisakazu Ohtani
Journal:  J Pharm Health Care Sci       Date:  2021-07-01

6.  Effect of Sorbitol on the Pharmacokinetic Profile of Lamivudine Oral Solution in Adults: An Open-Label, Randomized Study.

Authors:  Kimberly Adkison; Allen Wolstenholme; Yu Lou; Zhiping Zhang; Amy Eld; Teodora Perger; Harald Vangerow; Katy Hayward; Mark Shaefer; Cynthia McCoig
Journal:  Clin Pharmacol Ther       Date:  2017-12-11       Impact factor: 6.875
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.